With the emergence and long-term Impact of COVID-19, Global Erythropoietin Drugs Market to reach USD 7.7 billion by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Erythropoietin Drugs Market points towards a potential rise to USD 7.7 billion by 2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that stimulates the production of red blood cells in the bone marrow, a process known as erythropoiesis. Initially developed to address anemic conditions arising from End-Stage Renal Disease (ESRD) and related treatments such as dialysis, EPO drugs have expanded their applications. Following successful Post-abbreviated New Drug Application (ANDA) approvals, EPO drugs have been increasingly sanctioned for managing chemotherapy-induced anemia. The market growth is driven by key factors such as the rising incidence of chronic diseases and the rising number of CKD cases.
Geographically, the global Erythropoietin Drugs market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the overall erythropoietin drugs market in terms of the revenue share of XX% in 2022. The regional market is anticipated to significantly benefit from local organizations that are actively engaged in advancing the development and use of erythropoietin drugs. Along with this, Asia Pacific is expected to witness fastest growth with CAGR XX% over the forecast period. The growth of the region is attributed to the presence of key players in the market and strategic initiatives undertaken by them to develop and commercialize new erythropoietin drug products to treat anemia patients.
The global Erythropoietin Drugs market is highly competitive owing to the presence of several key players such as Teva Pharmaceutical Industries Ltd. Johnson & Johnson Services, Inc. Intas Pharmaceuticals Ltd. Novartis AG Amgen, Inc. F. Hoffmann-La Roche Ltd. LG Chem Biocon Sun Pharmaceutical Industries Ltd Dr. Reddy’s Laboratories Ltd and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Erythropoietin Drugs Market is anticipated to grow with a healthy growth rate of more than 1.5% over the forecast period 2023-2030.
- In the Type segment, Biologics emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to advancing the development and use of erythropoietin drugs in the region.
- Asia Pacific is expected to grow at higher rate owing to strategic initiatives undertaken by them to develop and commercialize new erythropoietin drug products to treat anemia patients in the region.
Bizwit Research & Consulting has considered following segments for the study:
By Product:
- Erythropoietin
- Darbepoetin-alfa
By Type:
- Biologics
- Biosimilars
By Application:
- Cancer
- Renal Diseases
- Neurology
- Others
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone: +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
